Paper85683
The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells.
Miller SD and 2 others. J Exp Med, 1979. Cited by 222 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells. Papers, record 85683. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/85683
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immune Tolerance | Major topic |
| Immunity, Cellular | Major topic |
| Lymphocytes | Major topic |
| Membrane Proteins | Major topic |
| Proteins | Major topic |
| Animals | |
| Cytochrome c Group | |
| Dose-Response Relationship, Immunologic | |
| Female | |
| Immunosuppression Therapy | |
| Mice | |
| Mice, Inbred BALB C | |
| Solubility | |
| Spleen | |
| gamma-Globulins |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,084,399 | Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. | J Exp Med | 1976 | https://conductscience.org/library/papers/1084399 | PubMed |
| 2 | 1,084,899 | Requirements for induction of T cell tolerance to DNFB: efficiency of membrane-associated DNFB. | J Immunol | 1976 | https://conductscience.org/library/papers/1084899 | PubMed |
| 3 | 1,086,779 | Suppressor cell induction in vitro. II. Cellular requirements of suppressor cell induction. | Eur J Immunol | 1976 | https://conductscience.org/library/papers/1086779 | PubMed |
| 4 | 1,086,885 | Role of self-carriers in the immune response and tolerance. I. B-cell unresponsiveness and cytotoxic T-cell immunity induced by haptenated syngeneic lymphoid cells. | J Exp Med | 1976 | https://conductscience.org/library/papers/1086885 | PubMed |
| 5 | 1,087,316 | The induction of hapten-specific T cell tolerance by using hapten-modified lymphoid cells. I. Characteristics of tolerance induction. | J Immunol | 1976 | https://conductscience.org/library/papers/1087316 | PubMed |
| 6 | 1,101,472 | The role of specific suppressor T cells in immune tolerance. | Transplant Rev | 1975 | https://conductscience.org/library/papers/1101472 | PubMed |
| 7 | 1,254,950 | Tolerance and contact sensitivity to DNFB in mice. V. Induction of tolerance with DNP compounds and with free and membrane-associated DNFB. | J Immunol | 1976 | https://conductscience.org/library/papers/1254950 | PubMed |
| 8 | 1,273,519 | A comparison of four methods for measuring cutaneous delayed- type hypersensitivity reactions to protein antigens in the mouse. | Scand J Immunol | 1976 | https://conductscience.org/library/papers/1273519 | PubMed |
| 9 | 14,283,201 | PHAGOCYTOSIS OF THE ANTIGEN, A CRUCIAL STEP IN THE INDUCTION OF THE PRIMARY RESPONSE. | Proc Natl Acad Sci U S A | 1965 | https://conductscience.org/library/papers/14283201 | PubMed |
| 10 | 300,756 | The role of the macrophage as the stimulator cell in contact sensitivity. | J Immunol | 1977 | https://conductscience.org/library/papers/300756 | PubMed |
| 11 | 301,091 | The induction of hapten-specific T cell tolerance using hapten-modified lymphoid membranes. II. Relative roles of suppressor T cells and clone inhibition in the tolerant state. | Eur J Immunol | 1977 | https://conductscience.org/library/papers/301091 | PubMed |
| 12 | 303,257 | A splenic requirement for the generation of suppressor T cells. | J Immunol | 1977 | https://conductscience.org/library/papers/303257 | PubMed |
| 13 | 304,865 | Tolerance and contact sensitivity to DNFA in mice. VIII. Identification of distinct T cell subpopulations that mediate in vivo and in vitro manifestations of delayed hypersensitivity. | J Immunol | 1978 | https://conductscience.org/library/papers/304865 | PubMed |
| 14 | 305,458 | Genetic restrictions for the induction of suppressor T cells by hapten-modified lymphoid cells in tolerance to 1-fluoro-2,4-dinitrobenzene contact sensitivity. Role of the H-2D region of the major histocompatibility complex. | J Exp Med | 1978 | https://conductscience.org/library/papers/305458 | PubMed |
| 15 | 329,141 | Ia antigen expression on human epidermal Langerhans cells. | Nature | 1977 | https://conductscience.org/library/papers/329141 | PubMed |
| 16 | 4,103,727 | Cellular events during induction of immunologic unresponsiveness in adult mice. | J Immunol | 1971 | https://conductscience.org/library/papers/4103727 | PubMed |
| 17 | 4,130,110 | Failure to induce tolerance to 2,4-dinitrochlorobenzene contact sensitivity with a 2,4-dinitrophenyl (DNP) conjugate of a copolymer of D-glutamic acid and D-lysine, a specific tolerogen for DNP B cells. | J Immunol | 1974 | https://conductscience.org/library/papers/4130110 | PubMed |
| 18 | 4,179,469 | Studies on the induction of immunologic unresponsiveness. 3. Antigen form and mouse strain variation. | J Immunol | 1969 | https://conductscience.org/library/papers/4179469 | PubMed |
| 19 | 4,397,662 | Carrier function in anti-hapten antibody responses. IV. Experimental conditions for the induction of hapten-specific tolerance or for the stimulation of anti-hapten anamnestic responses by "nonimmunogenic" hapten-polypeptide conjugates. | J Exp Med | 1971 | https://conductscience.org/library/papers/4397662 | PubMed |
| 20 | 4,399,614 | Brain-associated theta antigen: reactivity of rabbit anti-mouse brain with mouse lymphoid cells. | Cell Immunol | 1971 | https://conductscience.org/library/papers/4399614 | PubMed |
Cited by76
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 222 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,842,659 | Kupffer cells are key mediators of antigen-specific immune tolerance by peptide-coupled red blood cells. | Sci Adv | 2026 | https://conductscience.org/library/papers/42842659 | PubMed |
| 41,499,508 | Allospecific splenic Tr1 cells drive effector T cell exhaustion through up-regulated Areg-EGFR signaling to promote transplant tolerance. | Sci Adv | 2026 | https://conductscience.org/library/papers/41499508 | PubMed |
| 41,481,727 | STING/type I interferon pathway is required for antigen-containing PLGA nanoparticle- and apoptotic cell-induced CD4+ T cell tolerance. | Sci Adv | 2026 | https://conductscience.org/library/papers/41481727 | PubMed |
| 40,103,389 | Current status of xenotransplantation from an immunobiological standpoint. | Clin Transplant Res | 2025 | https://conductscience.org/library/papers/40103389 | PubMed |
| 38,694,761 | Biomaterial-enhanced treg cell immunotherapy: A promising approach for transplant medicine and autoimmune disease treatment. | Bioact Mater | 2024 | https://conductscience.org/library/papers/38694761 | PubMed |
| 38,086,932 | Therapeutic induction of antigen-specific immune tolerance. | Nat Rev Immunol | 2024 | https://conductscience.org/library/papers/38086932 | PubMed |
| 36,221,192 | Nanoparticle dose and antigen loading attenuate antigen-specific T-cell responses. | Biotechnol Bioeng | 2023 | https://conductscience.org/library/papers/36221192 | PubMed |
| 34,987,468 | Can Immune Tolerance Be Re-established in Neuromyelitis Optica? | Front Neurol | 2021 | https://conductscience.org/library/papers/34987468 | PubMed |
| 33,854,514 | Emerging Therapeutics for Immune Tolerance: Tolerogenic Vaccines, T cell Therapy, and IL-2 Therapy. | Front Immunol | 2021 | https://conductscience.org/library/papers/33854514 | PubMed |
| 32,296,421 | The Emerging Jamboree of Transformative Therapies for Autoimmune Diseases. | Front Immunol | 2020 | https://conductscience.org/library/papers/32296421 | PubMed |
| 31,508,270 | Immunomodulatory Nanosystems. | Adv Sci (Weinh) | 2019 | https://conductscience.org/library/papers/31508270 | PubMed |
| 31,337,690 | Apoptotic Cell-Induced, Antigen-Specific Immunoregulation to Treat Experimental Antimyeloperoxidase GN. | J Am Soc Nephrol | 2019 | https://conductscience.org/library/papers/31337690 | PubMed |
| 30,944,161 | Nanoparticles Bearing TSH Receptor Protein and a Tolerogenic Molecule Do Not Induce Immune Tolerance but Exacerbate Thyroid Autoimmunity in hTSHR/NOD.H2h4 Mice. | J Immunol | 2019 | https://conductscience.org/library/papers/30944161 | PubMed |
| 30,804,535 | Antigen-specific therapeutic approaches for autoimmunity. | Nat Biotechnol | 2019 | https://conductscience.org/library/papers/30804535 | PubMed |
| 30,418,444 | Polymeric micro- and nanoparticles for immune modulation. | Biomater Sci | 2018 | https://conductscience.org/library/papers/30418444 | PubMed |
| 30,352,312 | Overcoming challenges in treating autoimmuntity: Development of tolerogenic immune-modifying nanoparticles. | Nanomedicine | 2019 | https://conductscience.org/library/papers/30352312 | PubMed |
| 28,414,079 | In vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance. | Adv Drug Deliv Rev | 2017 | https://conductscience.org/library/papers/28414079 | PubMed |
| 27,648,463 | Restoring immune tolerance in neuromyelitis optica: Part I. | Neurol Neuroimmunol Neuroinflamm | 2016 | https://conductscience.org/library/papers/27648463 | PubMed |
| 27,131,971 | Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis. | J Transl Med | 2016 | https://conductscience.org/library/papers/27131971 | PubMed |
| 26,568,117 | Manipulating regulatory T cells: a promising strategy to treat autoimmunity. | Immunotherapy | 2015 | https://conductscience.org/library/papers/26568117 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/85683
GET https://conductscience.org/api/papers/v1/85683/references?page=2